Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications.
Chapman
W C
WC
Lockstadt
H
H
Singla
N
N
Kafie
F E
FE
Lawson
J H
JH
D000918:Antibody Specificity; D004311:Double-Blind Method; D005781:Gelatin Sponge, Absorbable; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D011994:Recombinant Proteins; D013917:Thrombin / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*
D007518:Isoantibodies; D011994:Recombinant Proteins; D013917:Thrombin